Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ilyang Flu Vaccine in Healthy Children
NCT02263131Phase 3Completed
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Whole Inactivated Vaccines
01
Overview
A Phase 3 trial of Ilyang Flu Vaccine in influenza, sponsored by Il-Yang Pharmaceutical. Started Oct 2013; status: completed.
02
Drugs
Ilyang Flu Vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02263131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02263131.